Glenmark to start trial combining 2 anti-viral drugs on India Covid patients
New Delhi, May 26 Glenmark Pharmaceuticals announced on Tuesday that it will commence another new Phase 3 clinical trial on a combination of two anti-viral drugs Favipiravir and Umifenovir in hospitalized patients of moderate COVID-19 in India. Glenmark has received
